Shares of Abercrombie & Fitch soar 15%, as retailer blows past Wall Street’s expectations

Shares of Abercrombie & Fitch soar 15%, as retailer blows past Wall Street’s expectations


An Abercrombie & Fitch store in San Francisco.

Getty Images

Shares of Abercrombie & Fitch soared in premarket trading, after the retailer crushed Wall Street’s earnings and sales expectations for the quarter and raised its forecast for the year.

Here’s how the retailer did in the fiscal second quarter ended July 29 compared with what Wall Street expected, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.10 vs. 17 cents expected
  • Revenue: $935.3 million vs $842.4 million expected

Net income for the three-month period rose to $56.9 million, or $1.10 per share, from a loss of $16.8 million, or 33 cents a share, in the year-ago period.

Net sales rose from $805.1 million in the year prior.

Abercrombie said it now anticipates net sales will rise by about 10% for the full fiscal year, up from $3.7 billion in the prior year. It had previously expected growth of between 2% and 4%.

It said it expects operating margins to improve, too, as costs of freight and raw materials fall. It anticipates operating margins to be in the range of 8% to 9%, compared with prior expectations of 5% to 6%.

The retailer’s sales and its stock price have shot up, as Abercrombie has reinvented its image from a mall store known for shirtless models and a strong scent of cologne to a retailer that resonates with a broader audience.

As of Tuesday’s close, shares of Abercrombie had shot up about 80% this year, far outpacing the approximately 14% gains of the S&P 500. Shares of the company touched a 52-week high of $43.47 earlier this week.

Abercrombie also has stood out because it’s defied industry-wide trends. Retailers including Home Depot, Target and Walmart have all spoken about consumers who aren’t spending as freely on discretionary items, such as clothing. Foot Locker echoed similar sentiments, as its sales plummeted and it cut full-year guidance on Wednesday.

This is a developing story. Please check back for updates.



Source

Trump says Makary is out as FDA commissioner, following industry and White House backlash
Business

Trump says Makary is out as FDA commissioner, following industry and White House backlash

Dr. Marty Makary is out as FDA commissioner, President Donald Trump said Tuesday, ending a controversial tenure at the health agency. Makary is “a wonderful man and he’s going to be off, and the assistant, the deputy, is taking over temporarily,” Trump told reporters on Tuesday. He added, “He’s going to go on, and he’s […]

Read More
The summer box office is off to a hot start as weekend ticket sales top 0 million
Business

The summer box office is off to a hot start as weekend ticket sales top $160 million

The summer box office is off to a sizzling start — and it’s only getting started. Over the weekend, domestic ticket sales topped $161 million, a nearly 88% improvement over the same three-day frame in 2025. Disney and 20th Century Studio’s “The Devil Wears Prada 2” led the pack, adding $41.6 million during its second […]

Read More
Laid off GM employees describe ominous meeting, AI and severance
Business

Laid off GM employees describe ominous meeting, AI and severance

DETROIT — An ominous email about an oddly timed 15-minute virtual meeting. A scripted message from human resources. And an abrupt end to that meeting, as well as their job. That’s how several General Motors employees who were laid off Monday by the Detroit automaker described their jobs being terminated to CNBC. “No appreciation or […]

Read More